Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin

Atherosclerosis

Volumn 172, Issue 2, 2004, Pages 259-265

  Yamaguchi, Yu ^a   Matsuno, Sachiko ^a   Kagota, Satomi ^a   Haginaka, Jun ^a   Kunitomo, Masaru ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

3 Nitrotyrosine; Cigarette smoke extracts; Fluvastatin; Low density lipoprotein (LDL); Oxidative modification; Peroxynitrite; WHHL rabbit

Indexed keywords

3 NITROTYROSINE; ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN B; CIGARETTE SMOKE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PEROXYNITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FRACTIONATION; CHEMICAL MODIFICATION; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL MODEL; FEMALE; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LIFESTYLE; LIPOPROTEIN METABOLISM; MALE; NITRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

EID: 0842303100     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.09.030     Document Type: Article

References (36)

1. Ross R. The pathogenesis of atherosclerosis - an update. N. Eng. J. Med. 314:1986;488-500.
2. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
3. Steinberg D., Lewis A. Conner Memorial lecture. Oxidative modification of LDL and atherogenesis. Circulation. 95:1997;1062-1071.
4. O'Leary V.J., Darley-Usmar V.M., Russell L.J., Stone D. Pro-oxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein. Bichem. J. 292:1992;631-634.
5. Hogg N., Darley-Usmar V.M., Wilson M.T., Moncada S. The oxidation of alpha-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett. 326:1993;199-203.
6. Parthasarathy S, Santanam N. Mechanisms of oxidation, anti-oxidants, and atherosclerosis. Curr Opin Lipidol 1994;5:371-5.
7. Patel R.P., Diczfalusy U., Dzeletovic S., Wilson M.T., Darley-Usmar V.M. Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. J. Lipid Res. 37:1996;2361-2371.
8. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. FEBS Lett. 350:1994;9-12.
9. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
10. Squadrito G.L., Pryor W.A. Oxidative chemistry of nitric oxide: the role of superoxide, peroxynitrite, and carbon dioxide. Free Radic. Biol Med. 25:1998;392-403.
11. Marek W.R., Salas E. Nitric oxide - biological mediator, modulator and factor of injury; its role in the pathogenesis of atherosclerosis. Atherosclerosis. 118:1995;S69-S80.
12. Yokode M., Kita T., Arai H., Kawai C., Narumiya S., Fujiwara M. Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc. Natl. Acad. Sci. U.S.A. 85:1988;2344-2348.
13. Kagota S., Yamaguchi Y., Shinozuka K., Kwon Y.M., Kunitomo M. Cigarette smoke-modified low density lipoprotein impairs endothelium-dependent relaxation in isolated rabbit arteries. Gen. Pharmcol. 27:1996;477-481.
14. Yamaguchi Y., Kagota S., Haginaka J., Kunitomo M. Evidence of modified LDL in the plasma of hypercholesterolemic WHHL rabbits injected with aqueous extracts of cigarette smoke. Enviro. Toxicol. Pharmacol. 8:2000;255-260.
15. Yamaguchi Y., Matsuno S., Kagota S., Haginaka J., Kunitomo M. Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits. Atherosclerosis. 156:2001;109-117.
16. Yamaguchi Y., Kagota S., Haginaka J., Kunitomo M. Peroxynitrite- generating species: good candidate oxidants in aqueous extracts of cigarette smoke. Jpn. J. Pharmacol. 82:2000;78-81.
17. Yamaguchi Y., Kagota S., Haginaka J., Kunitomo M. Participation of peroxynitrite in oxidative modification of LDL by aqueous extracts of cigarette smoke. FEBS Lett. 512:2002;218-222.
18. Hussein O., Schlezinger S., Rosenblat M., Keidar S., Aviram M. Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis. 128:1997;11-18.
19. Aviram M., Hussein O., Rosenblat M., Schlezinger S., Hayek T., Keidar S. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy. J. Cardiovasc. Pharmacol. 31:1998;39-45.
20. Rikitake Y., Kawashima S., Takeshita S., Yamashita T., Azumi H., Yasuhara M.et al. Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in choelsterol-fed rabbits. Atherosclerosis. 154:2001;87-96.
21. Inoue T., Hayashi M., Takayanagi K., Morooka S. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients. Atherosclerosis. 160:2002;369-376.
22. Hatch F.T., Lees R.S. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6:1968;1-68.
23. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. Kunitomo M., Yamaguchi Y., Matsushima K., Bando Y. Cholesterol metabolism in serum and aorta of inbred mice fed a high-cholesterol diet. Japan J. Pharmacol. 34:1984;153-158.
25. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216.
26. Pryor W.A., Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann. N. Y. Acad. Sci. 686:1993;12-28.
27. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356:1998;1-11.
28. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 99:1997;2075-2081.
29. Yamamoto A., Hoshi K., Ichihara K. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes. Eur. J. Pharmacol. 361:1998;143-149.
30. Yamaguchi Y., Matsuno S., Kagota S., Haginaka J., Kunitomo M. Fluvastatin reduces modification of low-density lipoprotein in hyperlipidemic rabbit loaded with oxidative stress. Eur. J. Pharmacol. 436:2002;97-105.
31. Balavoine G.G., Geletii Y.V. Peroxynitrite scavenging by different antioxidants. Part I. Convenient assay. Nitric Oxide. 3:1999;40-54.
32. Ishii M., Shimizu S., Momose K., Yamamoto T. SIN-1-induced bytotoxicity in cultured endothelial cells involves reactive oxygen species and nitric oxide: protective effect of sepiapterin. J. Cardiovasc. Pharmacol. 33:1999;295-300.
33. Morre K.P., Darley-Usmar V., Morrow J., Roverts L.J. II Formation of F2-isoprostanes during oxidation of hyman low-density liporotein and plasma by peroxynitrite. Circ. Res. 77:1995;335-341.
34. Carr A.C., McCall M.R., Frei B. Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arterioscler. Thromb. Vasc. Biol. 20:2000;1716-1723.
35. Hazen S.L., Zhang R., Shen Z., Wu W., Podrez E.A., MacPherson J.C.et al. Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation in vivo. Circ. Res. 85:1999;950-958.
36. Petruzzelli S., Puntoni R., Mimotti P., Pulera N., Baliva F., Fornai E. et al. Plasma 3-nitrotyrosine in cigarette smokers. Am. J. Respir. Crit. Care Med. 156:1997;1907-1920.